Microcrystalline cellulose is a partially depolymerized cellulose that can be commonly used as an excipient in pharmaceutical formulations. It is produced from a variety of pure cellulose sources like cotton linters and wood pulp via an alkaline treatment process which results in a white, odorless, crystalline powder. As MCC is chemically inert and stable across a wide range of temperatures, it is highly favored as a binding agent, diluent, suspension agent, and tableting aid in tablets, capsules, and other dosage forms. With advantageous properties like high compression ability, desirable flow characteristics, and low moisture absorption, microcrystalline cellulose has emerged as a versatile pharmaceutical excipient for use in numerous drug delivery systems.
Market Dynamics:
The global microcrystalline cellulose market is projected to witness significant growth over the forecast period owing to various drivers such as rising generic drug production, increasing pharmaceutical R&D investments, and growth of the oral drug delivery segment. Additionally, the ability of MCC to reduce production costs for drug manufacturers by enabling product miniaturization and high-speed tableting is also fueling its demand. However, price fluctuations of raw materials may pose a hindrance to the market expansion. On the other hand, the growing preference for excipient outsourcing over in-house manufacturing as well as innovations in specialized grades of MCC for controlled release formulations present lucrative opportunities for market players.
Key Features of the Study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook